No, Lifeblood stopped collecting convalescent plasma at the end of March 2021. There is increasing evidence from clinical trials that convalescent plasma does not alter outcomes for hospitalised patients. Therefore, given the limited new cases in Australia, limited patients in hospital and evidence of limited efficacy, the clinical trials in Australia have ceased. There is some evidence that convalescent plasma could help people with a suppressed immune system and we continue to monitor research in this space. However, we do not anticipate a significant role, if any, for convalescent plasma from recovered individuals given vaccination induces a superior immune response.